TrialThe journal of headache and pain2025

Long-term tolerability and effectiveness of eptinezumab in Japanese adults with chronic migraine: results of the 60-week open-label SUNSET trial.

Takao Takeshima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.